Publicacions en col·laboració amb investigadors/es de Wellcome Trust Sanger Institute (17)

2024

  1. An atlas of cells in the human tonsil

    Immunity, Vol. 57, Núm. 2, pp. 379-399.e18

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  2. Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study

    Parasites and Vectors, Vol. 14, Núm. 1

  3. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by Treg cells

    Nature, Vol. 583, Núm. 7816, pp. 447-452

2019

  1. Corrigendum: Genetic and Phenotypic Characterization of the Etiological Agent of Canine Orchiepididymitis Smooth Brucella sp. BCCN84.3 (Frontiers in Veterinary Science, (2019), 6, 10.3389/fvets.2019.00175)

    Frontiers in Veterinary Science

  2. Genetic and phenotypic characterization of the etiological agent of canine orchiepididymitis smooth Brucella sp. BCCN84.3

    Frontiers in Veterinary Science, Vol. 6, Núm. JUN

2017

  1. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

    Oncogene, Vol. 36, Núm. 19, pp. 2737-2749

2016

  1. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

    Science Translational Medicine, Vol. 8, Núm. 341

  2. Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-κB inflammatory pathway

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Núm. 7, pp. 1871-1876

2015

  1. Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms

    Nature Communications, Vol. 6

  2. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype

    Leukemia, Vol. 29, Núm. 5, pp. 1177-1185

2014

  1. Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom

    Journal of Virology, Vol. 88, Núm. 22, pp. 13269-13283

2009

  1. Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum

    PLoS Biology, Vol. 7, Núm. 4, pp. 0771-0788

2003

  1. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms

    Genes Chromosomes and Cancer, Vol. 37, Núm. 4, pp. 421-426